Effect of Ayurvedic medicine in the Prophylaxis for COVID-19 of AYUSH healthcare workers , Dept of AYUSH, TS & CCRAS- NIIMH, Hyderabad.

Prospective open label observational study on the effect of AYUSH-64, Samshamani vati & Chyavanprash- (Ayurvedic Raksha Kit-l) as Prophylactic measure among AYUSH healthcare workers working in the vicinity of COVID -19 facilities.

Status

Recruiting

Phases

Phase 2Phase 3

Study type

Observational

Source

CTRI

Registry ID

CTRI/2020/06/025561

Enrollment

500

Registered

2020-06-03

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: RAKSHA KIT-1: Chavanprash, 10 grams once aday Samshamani vati 250 mg 2 times a day & AYUSH 64 500 mg 2 times a day Control Intervention1: Standard Prophylactic Care: Standard Prophylact

Eligibility

Inclusion criteria

Inclusion criteria: 1. AYUSH health care workers working within the facilities of COVID-19 duties. 2. Subjects who are from a community where at least 1 confirmed case is already identified. 3. Subjects who are ready to provide written/digital informed consent and who are willing to participate and follow the protocol requirements of the clinical study

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1. Pregnant and Lactating females. 2. Known cases of uncontrolled Diabetes and Hypertension. 3. Subjects having any medical or surgical condition that would require immediate medical or surgical intervention at the time of screening 4. Subjects having immune compromised status like HIV, Hepatitis, Tuberculosis, Cancer etc. 5. Subjects taking Steroid treatment and or any kind of immunosuppressive therapy 6. Subjects participating in any other clinical study or having participated in any other study 1 month prior to screening in the present study. 7. Subjects having a past history of allergy to any medicine that is part of the Ayurvedic intervention. 8. Other conditions, which in the opinion of the investigators, makes the patient unsuitable for enrolment or could interfere with his participation in, and completion of the protocol

Design outcomes

Primary

Measure	Time frame
Comparative assessment of occurrence of COVID-19 infection in healthy volunteers vis Police personal in community having at least 1 confirmed case already identified with control arm of Standard Prophylactic CareTimepoint: 0 day and 40th day Comparative assessment of occurrence of COVID-19 infection in healthy volunteers vis AYUSH personal in community having at least 1 confirmed case already identified with control arm of Standard Prophylactic Care	—

Measure

Time frame

Comparative assessment of occurrence of COVID-19 infection in healthy volunteers vis Police personal in community having at least 1 confirmed case already identified with control arm of Standard Prophylactic CareTimepoint: 0 day and 40th day Comparative assessment of occurrence of COVID-19 infection in healthy volunteers vis AYUSH personal in community having at least 1 confirmed case already identified with control arm of Standard Prophylactic Care

—

Secondary

Measure	Time frame
General health status of those who are taking Ayurveda preventive medicine.Timepoint: 3 months	—

Countries

India

Contacts

Public ContactDr Srikanth Babu Perugu

drperugu@gmail.com9849463878

Outcome results